|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home > Research Resources > Network of Translational Technologies (NeTT)
|
|
|
Network of Translational Technologies (NeTT)
|
|
|
|
 The future of biomedical research depends upon creatively integrated translational technologies used in pursuit of better health care. The primary goal of the Network of Translational Technologies (NeTT) of the CCTSI is to enable investigators with diverse areas of expertise to access and utilize a menu of biomedical technology cores and resources for their research. |
|
|
|
|
|
The Network of Translational Technologies program comprises 14 cores in 11 key technology areas that are critical to the mission of the CCTSI. The CCSTI NeTT Cores provide services to CCTSI members at subsidized rates.
|
Biobank Consortium
Scott M. Lucia, MD – 303.724.3470
Gene Expression & Microarray Analysis
Mark Geraci, MD – 303.724.6037
Metabolomics
Natalie Serkova, PhD – 303.724.1086
Proteomics Consortium
Robert S. Hodges, PhD – 303.724.3253
Nichole Reisdorph, PhD – 303.398.1964
Natalie Ahn, PhD – 303.492.4799
Medicinal Chemistry Core Facility
Michael Wempe, PhD – 303.724.8982
|
- Translational Therapeutics & Modeling
Vector Generation -
Diego Restrepo, PhD – 303.724.3405
Wallace Chick, PhD
Peter J. Koch, PhD – 303.724.0051
Imaging Consortium – Microscopy
Moshe Levi, MD – 303.724.4825
- Imaging Consortium – Experimental Human Imaging
Gerald (Chip) Dodd, MD – 720.848.6608
Small Animal Imaging
Natalie Serkova, PhD – 303.724.1086 | |
|
|
|
|
|
|
|
 |
|
|
|
|